Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser. - Wikidata - awgldk - TriplyDB

Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser.

Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser.

http://www.wikidata.org/entity/Q44664771

about

Development of a concept for a personalized approach in the perioperative antiplatelet therapy administration/discontinuation management based on multiple electrode aggregometry in patients undergoing coronary artery surgery.Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow.Rapid evaluation of platelet function using the Multiplate® Analyzer.Contemporary antiplatelet therapy in acute coronary syndromes: are there differences in outcomes and discontinuation between clopidogrel and ticagrelor?Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population.Time dependent reduction in platelet aggregation using the multiplate analyser and hirudin blood due to platelet clumping.Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome.Preoperative hemostatic testing and the risk of postoperative bleeding in coronary artery bypass surgery patients.Desmopressin in vitro effects on platelet function, monitored with Multiplate, ROTEM and Sonoclot.Assessing the influence of diurnal variations and selective Xa inhibition on whole blood aggregometry.Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial.Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response--the TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial.

P2860

Q38542821-376A1B67-12D7-4A28-A71B-F4651A711D48 Q39962890-83796DD2-EC60-4B0C-98DF-CF00652055C0 Q44398909-21DF5EDC-0D8A-4914-A484-6857CD914592 Q47258097-56E31B16-AC62-470A-983E-3F698EB13092 Q47763354-2E8F0C92-BC9A-4C1F-86EB-E18C8B4F3B33 Q49375827-9BB56CA3-B7CD-4BE9-A29C-D60FEA94A8F8 Q51059922-D9A3CE02-1061-4E2B-8CFE-ED373D6B2F09 Q51625232-899846B6-4260-41C0-A4DA-BDEC6F222DBE Q53164239-A6513740-2388-482F-B653-905C5A223414 Q53437152-E71E2733-1CE3-41EA-9A75-8ED49B807A52 Q53450451-75CCDBF4-217F-427D-8674-2049ED7D0F4F Q54580380-E977CB5F-6E00-45E0-A8A5-F11966D02EE4

P2860

Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser.

http://www.wikidata.org/entity/Q44664771

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Methodological considerations ...... sing the Multiplate® analyser.

@en

Methodological considerations ...... sing the Multiplate® analyser.

@nl

type

label

Methodological considerations ...... sing the Multiplate® analyser.

@en

Methodological considerations ...... sing the Multiplate® analyser.

@nl

prefLabel

Methodological considerations ...... sing the Multiplate® analyser.

@en

Methodological considerations ...... sing the Multiplate® analyser.

@nl

P1433

Q44664771-AC37C530-C533-4A9B-902E-7972A8BB7E52

P1476

Q44664771-289B1184-466C-48C0-8BDE-11110A9CE7AE

P2093

Q44664771-153D4DB1-7CCA-49EF-BF5C-F9F6F2CFAC5B

Q44664771-1716D6F7-F536-4FE5-BA6D-A1D7A7F9135B

Q44664771-54BBC760-73A2-4769-A77D-59003FB606D3

Q44664771-587B1831-ADF8-4706-B5FE-44590A264744

P2860

Q44664771-1A364BC6-F074-4600-8919-6EEA63327833

Q44664771-33757512-A23D-44FA-808E-BC4F3ED3E478

Q44664771-37F31CBD-60A2-4671-993A-A4E8AC31EA10

Q44664771-3C83AECB-BDC7-49A7-9C71-C260FFC2C456

Q44664771-4AEC063F-FE82-443D-B7F8-D761C4C6BF8F

Q44664771-62EFDD3A-84B4-4468-876F-BA024B926B08

Q44664771-7700AEAB-B3EB-441D-9186-A0299A306B66

Q44664771-8CF57985-AA6A-409F-8712-70AF908625C2

Q44664771-8DBA9F20-0A5B-4B4F-81C8-6867CF53D42F

Q44664771-951C5989-0A38-4478-BBA8-ECF8C50FAC34

P304

Q44664771-4D7BCA79-3A4F-40D8-B866-3D3E757C912E

P31

Q44664771-0D1C50B1-4C5D-4AF7-BAD3-A3548C6A4751

P356

Q44664771-7D4EEC5F-5D44-4316-9778-E112ABFD449B

P433

Q44664771-6D566F90-96CF-4242-B425-13718DDE2A16

P478

Q44664771-3FAF896A-2A4D-41CF-A233-8E551CB27D29

P577

Q44664771-56E3B42E-15BA-482E-9CCB-410891515B8A

P5875

Q44664771-92714597-AC32-4333-8D58-FC43263568AE

P698

Q44664771-F859090B-8577-4CF2-87AE-FAD6E2E13B6D

P356

09537104.2012.694086

P1433

P1476

Methodological considerations ...... sing the Multiplate® analyser.

@en

P2093

Anne C La Flamme

http://www.w3.org/2001/XMLSchema#string

Lisa R Johnston

http://www.w3.org/2001/XMLSchema#string

Peter D Larsen

http://www.w3.org/2001/XMLSchema#string

Scott A Harding

http://www.w3.org/2001/XMLSchema#string

P2860

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis.

Effect of heparin and heparin fractions on platelet aggregation

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin.

Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window.

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement.

Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay.

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.

Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.

P304

303-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09537104.2012.694086

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225294786

http://www.w3.org/2001/XMLSchema#string

P698

22686487

http://www.w3.org/2001/XMLSchema#string